The potential severity of these uncommon interactions warrants measures to avoid them.
John R. Horn, PharmD, FCCP, And Philip D. Hansten, PharmD, RPh
Advertisement
Articles by John R. Horn, PharmD, FCCP, And Philip D. Hansten, PharmD, RPh
Advertisement
Latest Updated Articles
- Statins and Macrolide Antibiotics: Defining the Risk
Published: August 2nd 2013 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Updated Indication for Upadacitinib in Patients With IBD
2
CDC Layoffs Raise Questions About the Future of Public Health Surveillance
3
Medetomidine: The Demon in the Illicit Fentanyl Supply
4
From $200,000 in Student Loan Debt to Becoming a 7-Figure Pharmacist
5
